The leukocyte integrin ␣ M  2 (Mac-1, CD11b/CD18) is a cell surface adhesion receptor for fibrinogen. The interaction between fibrinogen and ␣ M  2 mediates a range of adhesive reactions during the immune-inflammatory response. The sequence ␥ 383 TMKIIPFNRLTIG 395 , P2-C, within the ␥-module of the D-domain of fibrinogen, is a recognition site for ␣ M  2 and ␣ X  2 . We have now identified the complementary sequences within the ␣ M I-domain of the receptor responsible for recognition of P2-C. The strategy to localize the binding site for P2-C was based on distinct P2-C binding properties of the three structurally similar I-domains of Integrin ␣ M  2 participates in the attachment of leukocytes to the endothelial lining of blood vessels and the subsequent transmigration of adherent cells during immune-inflammatory responses (1-3). The engagement of fibrinogen (Fg) 1 by ␣ M  2 on the surface of leukocytes and by intercellular adhesion molecule-1 (ICAM-1) on the endothelium may play a role in mediating the adhesion of leukocytes to the vessel wall (4, 5) and in facilitating their subsequent extravasation across the endothelial monolayer (6). In addition, the binding of deposited fibrinogen or fibrin to ␣ M  2 may mediate leukocyte adhesion at extravascular sites of inflammation (7-9). In previous studies, Altieri et al. (10,11) demonstrated that a peptide (designated P1), corresponding to residues 190 -202 of the ␥-chain of the D-domain of Fg, was recognized by ␣ M  2 . However, when residues key to the recognition of P1 by ␣ M  2 -bearing cells were mutated in the ␥-module, ␥148 -411, this recombinant fragment was as active as its wild-type counterpart in supporting ␣ M  2 -mediated adhesion (12). This observation led to the search for additional ␣ M  2 recognition sites within the ␥-chain, and ultimately the P2 peptide, corresponding to ␥377-395, was identified (12). Indeed, in comparative analyses, P2 was 10 -15-fold more potent than P1 in inhibiting adhesion of the ␣ M  2 -expressing cells to the D fragment of Fg. Further analyses of the adhesion-promoting activity of overlapping peptides showed that its COOH-terminal part, ␥ 383 TMKI-IPFNRLTIG 395 , designated P2-C, was the primary site of its biological activity (12). Recently, a second leukocyte integrin, ␣ X  2 , which is highly homologous to ␣ M  2 , was demonstrated to bind to the ␥-module and P2-C peptide (13), and soluble P2-C peptide efficiently blocked the ␣ X  2 -mediated adhesion.Within the heterodimeric ␣ M  2 receptor, the I-domain, a region of ϳ200 amino acid residues, inserted in the ␣ M subunit, contributes broadly to the recognition of ligands by ␣ M  2 (14) and specifically to the binding of Fg to this integrin (14,15). In addition to Fg, this region also was implicated in the binding of ICAM-1(15), iC3b (16), and neutrophil inhibitory factor, NIF (17, 18). We have shown previously that P2 interacts with the recombinant ␣ M I-domain and that NIF partially blocked this interaction (12). Previous studies suggested that overla...